United Therapeutics (UTHR) News Today → Biggest hedge fund manager has huge warning for U.S. dollar (From Stansberry Research) (Ad) Free UTHR Stock Alerts $264.27 -1.78 (-0.67%) (As of 05:13 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineUnited Therapeutics (NASDAQ:UTHR) Reaches New 1-Year High at $268.72marketbeat.com - May 10 at 5:15 PMAnalysts Are Bullish on Top Healthcare Stocks: Olema Pharmaceuticals (OLMA), Arcus Biosciences (RCUS)markets.businessinsider.com - May 9 at 7:15 PM4,880 Shares in United Therapeutics Co. (NASDAQ:UTHR) Purchased by Empirical Financial Services LLC d.b.a. Empirical Wealth Managementmarketbeat.com - May 8 at 11:57 AMUnited Therapeutics Co. (NASDAQ:UTHR) CEO Martine A. Rothblatt Sells 3,600 Sharesamericanbankingnews.com - May 8 at 5:54 AMUnited Therapeutics Co. (NASDAQ:UTHR) CEO Sells $934,920.00 in Stockinsidertrades.com - May 8 at 5:53 AMInsider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR)finance.yahoo.com - May 7 at 5:19 AMInsider Sale: Director Judy Olian Sells Shares of United Therapeutics Corp (UTHR)finance.yahoo.com - May 7 at 5:19 AMUnited Therapeutics Co. (NASDAQ:UTHR) Director Christopher Causey Sells 2,240 Shares of Stockamericanbankingnews.com - May 7 at 4:36 AMUnited Therapeutics Co. (NASDAQ:UTHR) Director Christopher Causey Sells 2,240 Sharesinsidertrades.com - May 7 at 4:33 AM3 Biotech Stocks to Double Your Money in the Next 24 Monthsinvestorplace.com - May 6 at 2:30 PMUnited Therapeutics (NASDAQ:UTHR) Price Target Raised to $240.00americanbankingnews.com - May 6 at 2:04 AMUnited Therapeutics (NASDAQ:UTHR) Stock Rating Reaffirmed by HC Wainwrightamericanbankingnews.com - May 6 at 2:04 AMUnited Therapeutics (NASDAQ:UTHR) PT Raised to $400.00americanbankingnews.com - May 6 at 2:04 AMLSV Asset Management Lowers Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR)marketbeat.com - May 5 at 10:55 AMMartine A. Rothblatt Sells 3,600 Shares of United Therapeutics Co. (NASDAQ:UTHR) Stockamericanbankingnews.com - May 5 at 5:02 AMLos Angeles Capital Management LLC Boosts Stake in United Therapeutics Co. (NASDAQ:UTHR)marketbeat.com - May 4 at 10:26 AMUnited Therapeutics Co. (NASDAQ:UTHR) CEO Sells $929,124.00 in Stockinsidertrades.com - May 4 at 7:46 AMUnited Therapeutics (NASDAQ:UTHR) Sets New 12-Month High Following Analyst Upgradeamericanbankingnews.com - May 4 at 2:24 AMUnited Therapeutics (NASDAQ:UTHR) PT Raised to $240.00 at The Goldman Sachs Groupmarketbeat.com - May 3 at 8:08 PMUnited Therapeutics (NASDAQ:UTHR) Reaches New 1-Year High on Analyst Upgrademarketbeat.com - May 3 at 7:58 PMRussell Investments Group Ltd. Sells 33,986 Shares of United Therapeutics Co. (NASDAQ:UTHR)marketbeat.com - May 3 at 5:51 AMBuy Rating on United Therapeutics: Strong Market Position and Growth Potential Despite New Competitorsmarkets.businessinsider.com - May 2 at 9:58 PMSummit Global Investments Buys 12,095 Shares of United Therapeutics Co. (NASDAQ:UTHR)marketbeat.com - May 2 at 4:07 PMUnited Therapeutics (NASDAQ:UTHR) Posts Quarterly Earnings Results, Beats Expectations By $0.54 EPSmarketbeat.com - May 2 at 2:16 PMUnited Therapeutics (NASDAQ:UTHR) Price Target Raised to $400.00marketbeat.com - May 2 at 9:11 AMUnited Therapeutics (NASDAQ:UTHR) Rating Reiterated by HC Wainwrightmarketbeat.com - May 2 at 8:35 AMUnited Therapeutics Corp (UTHR) Q1 2024 Earnings Call Transcript Highlights: Record Revenue and ...finance.yahoo.com - May 2 at 8:29 AMUnited Therapeutics Co. (NASDAQ:UTHR) CEO Sells $847,260.00 in Stockinsidertrades.com - May 2 at 6:17 AMQ1 2024 United Therapeutics Corp Earnings Call Transcriptgurufocus.com - May 2 at 1:01 AMLung Disease-Focused United Therapeutics Says It Is A Compelling Investment Opportunitymsn.com - May 1 at 3:40 PMUTHR Stock Earnings: United Therapeutics Beats EPS, Beats Revenue for Q1 2024msn.com - May 1 at 3:40 PMUnited Therapeutics (NASDAQ:UTHR) Shares Up 7.3%marketbeat.com - May 1 at 1:23 PMUnited Therapeutics: Q1 Earnings Snapshotsfgate.com - May 1 at 9:56 AMUnited Therapeutics Corporation Reports First Quarter 2024 Financial Resultsfinance.yahoo.com - May 1 at 9:56 AMUnited Therapeutics Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performancefinance.yahoo.com - May 1 at 9:56 AMInsider Selling: United Therapeutics Co. (NASDAQ:UTHR) CEO Sells 3,600 Shares of Stockinsidertrades.com - April 30 at 4:04 AMabrdn plc Acquires Shares of 28,276 United Therapeutics Co. (NASDAQ:UTHR)marketbeat.com - April 28 at 5:29 AMIFM Investors Pty Ltd Takes $2.24 Million Position in United Therapeutics Co. (NASDAQ:UTHR)marketbeat.com - April 27 at 6:35 PMCORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney Transplantfinance.yahoo.com - April 26 at 4:17 PMCORRECTING and REPLACING PHOTO United Therapeutics Announces World's First Successful Xenothymokidney Transplantbusinesswire.com - April 26 at 2:02 PMUnited Therapeutics Reports First Successful Xenothymokidney Transplantmarketwatch.com - April 26 at 6:16 AMUnited Therapeutics (UTHR) Scheduled to Post Earnings on Wednesdaymarketbeat.com - April 25 at 11:45 AMPoplar Forest Capital LLC Sells 59,914 Shares of United Therapeutics Co. (NASDAQ:UTHR)marketbeat.com - April 25 at 12:14 AMLatest pig organ transplant in human marks milestone for Maryland companybizjournals.com - April 24 at 6:02 PMUnited Therapeutics Announces World’s First Successful Xenothymokidney Transplantfinance.yahoo.com - April 24 at 12:57 PMUnited Therapeutics Announces World's First Successful Xenothymokidney Transplantbusinesswire.com - April 24 at 9:00 AMUnited Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024businesswire.com - April 24 at 7:00 AMDuality Advisers LP Acquires 5,622 Shares of United Therapeutics Co. (NASDAQ:UTHR)marketbeat.com - April 23 at 7:52 AMZurcher Kantonalbank Zurich Cantonalbank Increases Holdings in United Therapeutics Co. (NASDAQ:UTHR)marketbeat.com - April 22 at 5:48 AMUnited Therapeutics CEO Martine Rothblatt sells $1.7m in stockinvesting.com - April 21 at 3:02 PM Get United Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for UTHR and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… UTHR Media Mentions By Week UTHR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. UTHR News Sentiment▼0.790.44▲Average Medical News Sentiment UTHR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. UTHR Articles This Week▼236▲UTHR Articles Average Week Get United Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for UTHR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BMRN News IONS News ALKS News MDGL News ALNY News FOLD News CTLT News SRPT News RDY News KRTX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:UTHR) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingYou need to know these two things about AI stocks ASAP…InvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
